PharmaSGP Holding SE
Develops & distributes natural, pharmacy-exclusive OTC drugs for chronic conditions in Europe.
PSG | F
Overview
Corporate Details
- ISIN(s):
- DE000A2P4LJ5
- LEI:
- 3912005CZ12PVVCIPT91
- Country:
- Germany
- Address:
- Lochhamer Schlag 1, 82166 Gräfelfing
- Website:
- https://pharmasgp.com/english/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
PharmaSGP Holding SE is a pharmaceutical company specializing in the development and distribution of a broad portfolio of over-the-counter (OTC) drugs and other healthcare products. The company focuses on pharmacy-exclusive products based on natural, chemical-free, and herbal active ingredients with documented efficacy and minimal known side effects. Its portfolio includes market-leading brands for various chronic indications such as pain therapy (RubaXX®, Restaxil®, Spalt®), sleep aids (Baldriparan®), and sexual weakness (DESEO®, Neradin®). Since its first product launch in 2012, PharmaSGP has expanded its business model across multiple European markets. The company went public in 2020 and significantly grew its portfolio by acquiring several established brands from GSK in 2021.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for PharmaSGP Holding SE and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-11 09:00 |
Earnings Release
PharmaSGP publishes preliminary half-year figures for 2025
|
English | 15.7 KB | |
| 2025-08-14 12:00 |
Delisting Announcement
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 1,315 additional shares…
|
English | 6.8 KB | |
| 2025-08-11 13:00 |
Delisting Announcement
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 39,678 additional share…
|
English | 6.8 KB | |
| 2025-08-08 11:47 |
Director's Dealing
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 873 additional shares o…
|
English | 6.8 KB | |
| 2025-08-07 13:11 |
Director's Dealing
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 1,505 additional shares…
|
English | 6.8 KB | |
| 2025-08-06 16:16 |
Delisting Announcement
PharmaSGP Holding SE: Delisting of PharmaSGP shares from Frankfurt Stock Exchan…
|
English | 7.8 KB | |
| 2025-08-05 10:48 |
Director's Dealing
PharmaSGP Holding SE: Michael Rudolf, Tender of 4,169 shares within the public …
|
English | 5.9 KB | |
| 2025-08-04 13:58 |
Delisting Announcement
PharmaSGP Holding SE: Dr. Clemens Fischer, Tender of a total of 6,062 addition…
|
English | 6.6 KB | |
| 2025-07-28 17:04 |
Delisting Announcement
PharmaSGP Holding SE publishes joint reasoned statement of the Management Board…
|
English | 9.2 KB | |
| 2025-07-28 14:11 |
Delisting Announcement
PharmaSGP Holding SE: FUTRUE GmbH, Tender of an additional total of 4,491 share…
|
English | 6.9 KB | |
| 2025-07-24 15:30 |
Director's Dealing
PharmaSGP Holding SE: FUTRUE GmbH, buy
|
English | 6.0 KB | |
| 2025-07-24 14:11 |
Delisting Announcement
FUTRUE GmbH submits request to implement squeeze-out of minority shareholders o…
|
English | 8.2 KB | |
| 2025-07-23 17:38 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 13.0 KB | |
| 2025-07-23 17:15 |
Director's Dealing
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 540 shares in PharmaSGP…
|
English | 6.6 KB | |
| 2025-07-18 11:57 |
Delisting Announcement
PharmaSGP Holding SE: Acceptance period for FUTRUE GmbHs public delisting tende…
|
English | 7.2 KB |
Automate Your Workflow. Get a real-time feed of all PharmaSGP Holding SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for PharmaSGP Holding SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-11-25 | FUTRUE GmbH | Close relation | Buy | None | 12,145,250.00 EUR |
| 2022-10-05 | MMI Leisure & Capital Management GmbH | Close relation | Buy | None | 125,383.20 EUR |
| 2022-10-05 | Hillen, Ingo | Board | Buy | None | 1,048.00 EUR |
| 2022-10-05 | MMI Leisure & Capital Management GmbH | Close relation | Buy | None | 26.60 EUR |
| 2022-05-30 | Wittig, Dr. Thomas | Supervisory board | Buy | None | 138,953.80 EUR |
| 2022-05-30 | Schröter, Jasmin | Close relation | Buy | None | 119,660.00 EUR |
| 2022-05-30 | Simon-Schröter, Dr. Wolfram | Other | Buy | None | 10,040.00 EUR |
| 2022-04-25 | FUTRUE GmbH | Close relation | Buy | None | 208,180.53 EUR |
| 2022-04-25 | MMI Leisure & Capital Management GmbH | Close relation | Sell | None | 197,193.60 EUR |
| 2022-04-25 | Bloching, Prof. Dr. Micha | Supervisory board | Sell | None | 171,825.00 EUR |
